On November 16, 2017, the Third Circuit Court of Appeals affirmed the grant of summary judgment in favor of CVS Caremark, Corp. (“CVS Caremark”), finding that although the lower court’s reasoning was flawed, the whistleblower Anthony Spay failed to establish
CVS customers denied class certification in lawsuit alleging overcharging for generic prescriptions
Posted on
On Tuesday, March 21st, the U.S. District Court for the Northern District of California denied class certification in a suit alleging that CVS had overcharged insurance companies for generic prescriptions, resulting in higher copayments for customers. Corcoran, et…
Challenge dropped to dismissal of allegations of pharmacy-reward fraud
Posted on
A relator is dropping his appeal of a district court decision that granted a motion to dismiss FCA claims against CVS. Procedural deficiencies were raised with relator’s appeal, including missing the filing deadline for his appeal in the U.S. Court…